1. Home
  2. HCM

as 03-28-2025 4:00pm EST

$
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
.
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
-
$
0
1
2
3
4
5
6
7
8
9
.
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
-
0
1
2
3
4
5
6
7
8
9
.
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

HUTCHMED (China) Ltd is an innovative biopharmaceutical company engaged in the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.

;SMA (50)$14.75EMA (200)$16.33O: $15.38 H: $15.57 L: $15.09 C: $15.25 −0.13 (−0.85%)Elder Ray 0.31, −0.17
Founded: 2000 Country:
Hong Kong
Hong Kong
Employees: N/A City: N/A
Market Cap: 2.6B IPO Year: N/A
Target Price: $19.00 AVG Volume (30 days): 84.4K
Analyst Decision: Hold Number of Analysts: 1
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: 0.04 EPS Growth: -66.28
52 Week Low/High: $12.84 - $21.92 Next Earning Date: 03-19-2025
Revenue: $630,201,000 Revenue Growth: -24.80%
Revenue Growth (this year): 28.98% Revenue Growth (next year): 20.41%

HCM Daily Stock ML Predictions

SELLHOLDBUYas of 14 hours ago

Share on Social Networks:

By browsing this website, you accept our Privacy Policy & Terms of Use